EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhanced Innate and Acquired Immune Responses in Systemic Sclerosis Primary Peripheral Blood Mononuclear Cells (PBMCs)

Iulia Szabo iD, Medeea Badii, Ildikó O Gaál, Robert Szabo iD, Radu A Popp, Leo A B Joosten, Tania O Crişan iD, Simona Rednic

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241914438 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Iulia Szabo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Leukocytes, Mononuclear, Scleroderma, Systemic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iuliu Hațieganu University of Medicine and Pharmacy, “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, doctoral research project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic immune activation in systemic sclerosis is supported by the production of a plethora of cytokines with proven regulatory activities of the immune responses. This study aimed to explore PBMCs’ cytokine profiles in SSc patients versus controls, as well as to investigate the balance between pro- and anti-inflammatory cytokines in association with disease duration. PBMCs were isolated from 18 SSc patients and 17 controls and further subjected to in vitro stimulation with lipopolysaccharide and heat-killed Candida albicans. Cytokine production was measured after 24 h and 7 days, respectively, using ELISA kits for interleukin (IL)-1β, IL-1 receptor antagonist (IL-1Ra), IL-6, tumor necrosis factor (TNF), IL-10, IL-17, and interferon-gamma (IFN-gamma). IL-1 β, IL-6, and TNF levels were increased in SSc patients compared with healthy volunteers irrespective of the stimulus used. IL-1Ra and Il-17 concentrations were not statistically different between groups, even though a trend toward higher levels in patients compared with their matched controls was also observed. Most cytokines demonstrated a stable course with disease progression, except for IL-10 levels, which declined over time. In conclusion, the results of this pilot study reveal that in patients with SSc a persistently enhanced immune response is established and maintained regardless of stimulus or disease duration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukocytes, MononuclearScleroderma, SystemicHumansInterleukin-10Interleukin-17Interleukin 1 Receptor Antagonist ProteinInterleukin-6Pilot ProjectsCytokinesTumor Necrosis Factor-alphaImmunity

Stichwörter der Autor:innen

PBMCscytokinesinnatesystemic sclerosis

Substanzen

Interleukin-10Interleukin-17Interleukin 1 Receptor Antagonist ProteinInterleukin-6CytokinesTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Department of Rheumatology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Department of Rheumatology, County Emergency Hospital, 400347 Cluj-Napoca, Romania.
  • Department of Medical Genetics, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Department of Internal Medicine, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
  • 2nd Anesthesia Department, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Department of Anesthesia and Intensive Care, County Emergency Hospital, 400347 Cluj-Napoca, Romania.

ORCID-Profile: Iulia Szabo, Robert Szabo, Tania O Crişan

Förderung

  • Iuliu Hațieganu University of Medicine and Pharmacy
  • “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca
  • doctoral research project

Zitieren

APA

Szabo, I., Badii, M., Gaál, I. O., Szabo, R., Popp, R. A., Joosten, L. A. B., Crişan, T. O., & Rednic, S. (2023). Enhanced Innate and Acquired Immune Responses in Systemic Sclerosis Primary Peripheral Blood Mononuclear Cells (PBMCs). International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241914438

Vancouver

Szabo I, Badii M, Gaál IO, Szabo R, Popp RA, Joosten LAB, et al. Enhanced Innate and Acquired Immune Responses in Systemic Sclerosis Primary Peripheral Blood Mononuclear Cells (PBMCs). International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241914438

BibTeX
@article{Szabo2023,
  author = {Szabo, Iulia and Badii, Medeea and Gaál, Ildikó O and Szabo, Robert and Popp, Radu A and Joosten, Leo A B and Crişan, Tania O and Rednic, Simona},
  title = {Enhanced Innate and Acquired Immune Responses in Systemic Sclerosis Primary Peripheral Blood Mononuclear Cells (PBMCs)},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241914438}
}
Kostenlos starten →